Glucose Control and the Effect of Empagliflozin on Kidney Outcomes in Type 2 Diabetes: An Analysis From the EMPA-REG OUTCOME Trial

Saved in:

Bibliographic Details
Published in	American journal of kidney diseases Vol. 74; no. 5; pp. 713 - 715
Main Authors	Cooper, Mark E., Inzucchi, Silvio E., Zinman, Bernard, Hantel, Stefan, von Eynatten, Maximilian, Wanner, Christoph, Koitka-Weber, Audrey
Format	Journal Article
Language	English
Published	United States Elsevier Inc 01.11.2019
Subjects	Benzhydryl Compounds - administration & dosage Blood Glucose - metabolism Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Diabetic Nephropathies - epidemiology Diabetic Nephropathies - etiology Diabetic Nephropathies - prevention & control Dose-Response Relationship, Drug Global Health Glucosides - administration & dosage Humans Prevalence Randomized Controlled Trials as Topic Risk Factors Sodium-Glucose Transporter 2 Inhibitors - administration & dosage Treatment Outcome
Online Access	Get full text
ISSN	0272-6386 1523-6838 1523-6838
DOI	10.1053/j.ajkd.2019.03.432

More Information
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 content type line 23
ISSN:	0272-6386 1523-6838 1523-6838
DOI:	10.1053/j.ajkd.2019.03.432